<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045554"><TermName>mycophenolate mofetil</TermName><TermPronunciation>(my-koh-FEH-noh-layt MOH-feh-til)</TermPronunciation><TermDefinition><DefinitionText>A drug used to prevent graft-versus-host disease (GVHD) after organ transplants. It is also being studied in the prevention of GVHD after stem cell transplants for cancer, and in the treatment of some autoimmune disorders. Mycophenolate mofetil is a type of immunosuppressive agent. Also called CellCept.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705587" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;mycophenolate mofetil&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705586" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;micofenolato mofetil&quot;" language="es" id="_4"/><SpanishTermName>micofenolato mofetil</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar la enfermedad de injerto contra huésped (EICH) después de trasplantes de órganos. Asimismo, está en estudio para la prevención de la EICH después de trasplantes de células madre para tratar el cáncer y para el tratamiento de algunos trastornos autoinmunitarios. Micofenolato mofetil es un tipo de inmunosupresor. También se llama CellCept.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2007-10-08</DateLastModified></GlossaryTerm>
